<p>Fortrea Holdings（纳斯达克股票代码：FTRE）在过去三个月内被 6 位分析师进行了分析，显示出从看涨到看跌的多样化观点。</p>
<p>下表提供了分析师最近评级的简明概述，展示了过去 30 天情绪的变化，并与前几个月进行了比较，以提供全面的视角。</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看涨</strong></th>
<th align="right"><strong>稍微看涨</strong></th>
<th align="right"><strong>无所谓</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>总评级</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>过去 30 天</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 个月前</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>分析师为 Fortrea Holdings 设定了 12 个月的价格目标，显示出平均目标为 15.5 美元，最高预估为 25.00 美元，最低预估为 9.00 美元。这一上升趋势显而易见，目前的平均值反映出比之前的平均价格目标 10.33 美元增加了 50.05%。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767736909_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="价格目标图表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767736909_0.png"/></p>
<h2>解读分析师评级：深入分析</h2>
<p>对最近分析师行动的深入分析揭示了金融专家对 Fortrea Holdings 的看法。以下总结概述了关键分析师、他们最近的评估以及对评级和价格目标的调整。</p>
<table>
<thead>
<tr>
<th>分析师</th>
<th>分析师公司</th>
<th>采取的行动</th>
<th>评级</th>
<th>当前价格目标</th>
<th>之前价格目标</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>上调</td>
<td>超越大盘</td>
<td>$25.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上调</td>
<td>中性</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上调</td>
<td>持平</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>上调</td>
<td>买入</td>
<td>$21.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上调</td>
<td>低于大盘</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上调</td>
<td>中性</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
<h3>关键洞察：</h3>
<ul>
<li><strong>采取的行动：</strong> 针对市场动态和公司表现的变化，分析师更新他们的建议。无论是 ‘维持’、‘上调’ 还是 ‘下调’ 他们的立场，都表明他们对 Fortrea Holdings 近期发展的反应。这为分析师对公司当前状态的看法提供了洞察。</li>
<li><strong>评级：</strong> 分析师揭示了对股票的定性评估，从 ‘超越大盘’ 到 ‘低于大盘’。这些评级提供了对 Fortrea Holdings 相对于更广泛市场表现的预期洞察。</li>
<li><strong>价格目标：</strong> 分析师提供了价格目标的洞察，给出对 Fortrea Holdings 股票未来价值的估计。这一比较揭示了分析师预期随时间变化的趋势。</li>
</ul>
<p>为了获取有关 Fortrea Holdings 市场表现的有价值洞察，请考虑将这些分析师评估与关键财务指标结合起来。保持信息灵通，利用我们的评级表做出明智的决策。</p>
<p>随时了解 Fortrea Holdings 的分析师评级。</p>
<p>如果您对跟踪小型股新闻和表现感兴趣，您可以从这里开始跟踪。</p>
<h2>关于 Fortrea Holdings</h2>
<p>Fortrea 是一家全球性的晚期合同研究组织，提供从第一阶段到第四阶段的临床试验管理、临床药理学和患者接入解决方案。该公司与新兴和大型生物制药、医疗设备和诊断公司合作，作为功能服务提供商、全方位服务提供商进行临床试验，并提供混合试验。2023 年，Fortrea 作为一家独立的上市公司成立，此前 Labcorp 将其临床开发业务剥离，该业务是通过 2015 年以 61 亿美元收购 Covance 而获得的。Fortrea 在 90 个国家拥有 19,000 名员工。</p>
<h3>Fortrea Holdings：深入财务分析</h3>
<p><strong>市值视角：</strong> 该公司的市值低于行业平均水平，表明其相较于同行规模相对较小。这一定位可能受到感知增长潜力或运营规模等因素的影响。</p>
<p><strong>收入增长：</strong> Fortrea Holdings 在过去 3 个月的收入增长显著。截至 2025 年 9 月 30 日，该公司的收入增长率约为 <strong>3.91%</strong>。这表明公司的顶线收益有了显著增加。与竞争对手相比，该公司面临困难，增长率低于医疗保健行业同行的平均水平。</p>
<p><strong>净利润率：</strong> Fortrea Holdings 的净利润率低于行业平均水平，表明在保持强劲盈利能力方面可能面临挑战。净利润率为 <strong>-2.27%</strong>，公司在有效成本管理方面可能面临困难。</p>
<p><strong>股本回报率（ROE）：</strong> Fortrea Holdings 的 ROE 低于行业标准，表明在有效利用股本方面存在困难。ROE 为 <strong>-2.72%</strong>，公司可能面临为股东提供满意回报的挑战。</p>
<p><strong>资产回报率（ROA）：</strong> Fortrea Holdings 的 ROA 低于行业平均水平，表明在有效利用资产方面存在挑战。ROA 为 <strong>-0.57%</strong>，公司可能面临从其资产中产生最佳回报的困难。</p>
<p><strong>债务管理：</strong> Fortrea Holdings 的债务与股本比率超过行业规范，达到 <strong>2.04</strong>。这表明公司承担了大量债务，可能面临财务挑战。</p>
<h2>什么是分析师评级？</h2>
<p>评级来自分析师或银行和金融系统内的专家，他们针对特定股票或定义的行业进行报告（通常每季度对每只股票进行一次）。分析师通常从公司电话会议和会议、财务报表以及与重要内部人士的对话中获取信息，以做出决策。</p>
<p>除了标准评估外，一些分析师还会对增长预估、收益和收入等指标提供预测，为投资者提供额外的指导。使用分析师评级的用户应注意，这些专业建议受到人类观点的影响，可能会存在变动。</p>
<p>本文由 Benzinga 的自动内容引擎生成，并经过编辑审核。</p>

FTRE

<p>Fortrea Holdings（纳斯达克代码：FTRE）在过去三个月内获得了 6 位分析师的混合评级，12 个月的平均目标价为 15.5 美元，较之前的目标价反映出 50.05% 的增长。分析师们提高了他们的评级，其中 Evercore ISI 和花旗集团等公司的增幅尤为显著。尽管收入增长了 3.91%，但 Fortrea 的财务指标，包括净利润率（-2.27%）和股本回报率（-2.72%），均低于行业平均水平，显示出潜在的挑战。该公司由 Labcorp 的分拆而成，作为一家全球合同研究组织，在 90 个国家拥有 19,000 名员工</p>

<p>Fortrea Holdings (NASDAQ: FTRE) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<div class="lb-trans"><p>Fortrea Holdings（纳斯达克股票代码：FTRE）在过去三个月内被 6 位分析师进行了分析，显示出从看涨到看跌的多样化观点。</p>
</div><p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<div class="lb-trans"><p>下表提供了分析师最近评级的简明概述，展示了过去 30 天情绪的变化，并与前几个月进行了比较，以提供全面的视角。</p>
</div><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看涨</strong></th>
<th align="right"><strong>稍微看涨</strong></th>
<th align="right"><strong>无所谓</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>总评级</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>过去 30 天</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 个月前</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</div><p>Analysts have set 12-month price targets for Fortrea Holdings, revealing an average target of $15.5, a high estimate of $25.00, and a low estimate of $9.00. This upward trend is evident, with the current average reflecting a 50.05% increase from the previous average price target of $10.33.</p>
<div class="lb-trans"><p>分析师为 Fortrea Holdings 设定了 12 个月的价格目标，显示出平均目标为 15.5 美元，最高预估为 25.00 美元，最低预估为 9.00 美元。这一上升趋势显而易见，目前的平均值反映出比之前的平均价格目标 10.33 美元增加了 50.05%。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767736909_0.png" alt="price target chart" original-src="https://www.benzinga.com/files/images/story/2026/1767736909_0.png"/></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<div class="lb-trans"><h2>解读分析师评级：深入分析</h2>
</div><p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Fortrea Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<div class="lb-trans"><p>对最近分析师行动的深入分析揭示了金融专家对 Fortrea Holdings 的看法。以下总结概述了关键分析师、他们最近的评估以及对评级和价格目标的调整。</p>
</div><table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>分析师</th>
<th>分析师公司</th>
<th>采取的行动</th>
<th>评级</th>
<th>当前价格目标</th>
<th>之前价格目标</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>上调</td>
<td>超越大盘</td>
<td>$25.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上调</td>
<td>中性</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上调</td>
<td>持平</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>上调</td>
<td>买入</td>
<td>$21.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上调</td>
<td>低于大盘</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上调</td>
<td>中性</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
</div><h3>Key Insights:</h3>
<div class="lb-trans"><h3>关键洞察：</h3>
</div><ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Fortrea Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Fortrea Holdings compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Fortrea Holdings's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>采取的行动：</strong> 针对市场动态和公司表现的变化，分析师更新他们的建议。无论是 ‘维持’、‘上调’ 还是 ‘下调’ 他们的立场，都表明他们对 Fortrea Holdings 近期发展的反应。这为分析师对公司当前状态的看法提供了洞察。</li>
<li><strong>评级：</strong> 分析师揭示了对股票的定性评估，从 ‘超越大盘’ 到 ‘低于大盘’。这些评级提供了对 Fortrea Holdings 相对于更广泛市场表现的预期洞察。</li>
<li><strong>价格目标：</strong> 分析师提供了价格目标的洞察，给出对 Fortrea Holdings 股票未来价值的估计。这一比较揭示了分析师预期随时间变化的趋势。</li>
</ul>
</div><p>For valuable insights into Fortrea Holdings's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<div class="lb-trans"><p>为了获取有关 Fortrea Holdings 市场表现的有价值洞察，请考虑将这些分析师评估与关键财务指标结合起来。保持信息灵通，利用我们的评级表做出明智的决策。</p>
</div><p>Stay up to date on Fortrea Holdings analyst ratings.</p>
<div class="lb-trans"><p>随时了解 Fortrea Holdings 的分析师评级。</p>
</div><p>If you are interested in following small-cap stock news and performance you can start by tracking it here.</p>
<div class="lb-trans"><p>如果您对跟踪小型股新闻和表现感兴趣，您可以从这里开始跟踪。</p>
</div><h2>About Fortrea Holdings</h2>
<div class="lb-trans"><h2>关于 Fortrea Holdings</h2>
</div><p>Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.</p>
<div class="lb-trans"><p>Fortrea 是一家全球性的晚期合同研究组织，提供从第一阶段到第四阶段的临床试验管理、临床药理学和患者接入解决方案。该公司与新兴和大型生物制药、医疗设备和诊断公司合作，作为功能服务提供商、全方位服务提供商进行临床试验，并提供混合试验。2023 年，Fortrea 作为一家独立的上市公司成立，此前 Labcorp 将其临床开发业务剥离，该业务是通过 2015 年以 61 亿美元收购 Covance 而获得的。Fortrea 在 90 个国家拥有 19,000 名员工。</p>
</div><h3>Fortrea Holdings: Delving into Financials</h3>
<div class="lb-trans"><h3>Fortrea Holdings：深入财务分析</h3>
</div><p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<div class="lb-trans"><p><strong>市值视角：</strong> 该公司的市值低于行业平均水平，表明其相较于同行规模相对较小。这一定位可能受到感知增长潜力或运营规模等因素的影响。</p>
</div><p><strong>Revenue Growth:</strong> Fortrea Holdings's revenue growth over a period of 3M has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately <strong>3.91%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<div class="lb-trans"><p><strong>收入增长：</strong> Fortrea Holdings 在过去 3 个月的收入增长显著。截至 2025 年 9 月 30 日，该公司的收入增长率约为 <strong>3.91%</strong>。这表明公司的顶线收益有了显著增加。与竞争对手相比，该公司面临困难，增长率低于医疗保健行业同行的平均水平。</p>
</div><p><strong>Net Margin:</strong> Fortrea Holdings's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-2.27%,</strong> the company may face hurdles in effective cost management.</p>
<div class="lb-trans"><p><strong>净利润率：</strong> Fortrea Holdings 的净利润率低于行业平均水平，表明在保持强劲盈利能力方面可能面临挑战。净利润率为 <strong>-2.27%</strong>，公司在有效成本管理方面可能面临困难。</p>
</div><p><strong>Return on Equity (ROE):</strong> Fortrea Holdings's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-2.72%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<div class="lb-trans"><p><strong>股本回报率（ROE）：</strong> Fortrea Holdings 的 ROE 低于行业标准，表明在有效利用股本方面存在困难。ROE 为 <strong>-2.72%</strong>，公司可能面临为股东提供满意回报的挑战。</p>
</div><p><strong>Return on Assets (ROA):</strong> Fortrea Holdings's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-0.57%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<div class="lb-trans"><p><strong>资产回报率（ROA）：</strong> Fortrea Holdings 的 ROA 低于行业平均水平，表明在有效利用资产方面存在挑战。ROA 为 <strong>-0.57%</strong>，公司可能面临从其资产中产生最佳回报的困难。</p>
</div><p><strong>Debt Management:</strong> Fortrea Holdings's debt-to-equity ratio surpasses industry norms, standing at <strong>2.04</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<div class="lb-trans"><p><strong>债务管理：</strong> Fortrea Holdings 的债务与股本比率超过行业规范，达到 <strong>2.04</strong>。这表明公司承担了大量债务，可能面临财务挑战。</p>
</div><h2>What Are Analyst Ratings?</h2>
<div class="lb-trans"><h2>什么是分析师评级？</h2>
</div><p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<div class="lb-trans"><p>评级来自分析师或银行和金融系统内的专家，他们针对特定股票或定义的行业进行报告（通常每季度对每只股票进行一次）。分析师通常从公司电话会议和会议、财务报表以及与重要内部人士的对话中获取信息，以做出决策。</p>
</div><p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<div class="lb-trans"><p>除了标准评估外，一些分析师还会对增长预估、收益和收入等指标提供预测，为投资者提供额外的指导。使用分析师评级的用户应注意，这些专业建议受到人类观点的影响，可能会存在变动。</p>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自动内容引擎生成，并经过编辑审核。</p>
</div>

专家展望：从 6 位分析师的视角看 Fortrea Holdings